Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



GFR-gränsen har sänkts för metformin vid typ 2-diabetes. Nya rekommendationer vid nedsatt njurfunktion och undersökning med jodkontrastmedel
Engelsk titel: Treatment with metformin in type 2 diabetes mellitus – new routines when renal function is reduced and in connection with administration of iodine contrast media Läs online Författare: Sterner, Gunnar ; Frid, Anders Språk: Swe Antal referenser: 23 Dokumenttyp: Artikel UI-nummer: 18040283

Tidskrift

Läkartidningen 2018;115(15)656-7 ISSN 0023-7205 E-ISSN 1652-7518 KIBs bestånd av denna tidskrift

Sammanfattning

Metformin is eliminated through glomerular filtration and tubular secretion in the kidneys. New guidelines recommend use of metformin down to a GFR of 30 mL/min under the condition that the dose is adjusted. As the risk of inducing lactic acidosis is very low in connection with administration of iodine contrast media, new recommendations in Sweden say that metformin must be stopped only when GFR is below 45 mL/min. Determination of metformin levels in serum is useful to guide therapeutic dose when GFR is low but also to confirm that lactic acidosis is caused by metformin.